Mechanism Overview

How AOD-9604 Works in Research Models

AOD-9604 is a synthetic peptide fragment corresponding to the C-terminal region of human growth hormone (hGH 177-191) with a tyrosine residue at the N-terminus. Researchers have studied it for lipolytic activity in adipose tissue models in the context of its structural derivation from the GH lipolytic domain. Published research distinguishes AOD-9604 from full GH by its documented absence of IGF-1 axis activation and anabolic receptor binding, focusing instead on fat metabolism regulatory mechanisms in preclinical adipose models. AOD-9604 has also been studied for potential cartilage and bone repair activity.

Beta-3 adrenergic receptor (adipose)Fat metabolism regulatory pathwaysAdiponectin signalingGH receptor (minimal binding documented)Cartilage repair pathway research

Mechanism Steps in Research Models

How researchers have characterized AOD-9604 activity in published preclinical studies.

1

Adipose Tissue Targeting

AOD-9604 corresponds to the C-terminal lipolytic domain of growth hormone identified through structure-activity relationship research. Published studies have characterized this domain as responsible for GH lipolytic activity in adipose tissue, with the fragment design focused on isolating fat metabolism effects from anabolic GH receptor effects.

2

Lipolytic Pathway Activation

Research in adipocyte cell culture and rodent adipose tissue models has documented AOD-9604 activating lipolytic pathways, measured through glycerol and free fatty acid release assays. Published studies have examined dose-response relationships in these in vitro and in vivo fat metabolism model systems.

3

Absence of IGF-1 Axis Stimulation

Published research has documented that AOD-9604 does not stimulate significant IGF-1 production or activate GH receptor anabolic signaling in animal models, distinguishing it mechanistically from full-length growth hormone and characterizing its selectivity for fat metabolism pathways.

4

Cartilage and Bone Research

Additional preclinical research has examined AOD-9604 in cartilage and bone repair paradigms, documenting potential activity in these tissue types independent of the primary lipolytic mechanism. Published Australian research examined AOD-9604 in joint and cartilage models, expanding its preclinical research profile beyond adipose biology.

Research Observations

Key findings documented in published preclinical studies.

Adipose Lipolysis Research

Published in vitro and in vivo adipose research has documented AOD-9604 stimulating lipolysis in rodent and cell culture models, with measured increases in glycerol and fatty acid release as primary outcome endpoints in published metabolism studies.

IGF-1 Axis Selectivity Studies

Published comparative research has documented AOD-9604 not stimulating significant IGF-1 axis activation in animal models, a finding that distinguishes it from full-length GH and supports its characterization as a selective lipolytic fragment.

Obesity and Metabolic Models

Rodent obesity model research has examined AOD-9604 in the context of adipose mass reduction, with published preclinical data documenting body fat changes in diet-induced obesity paradigms.

Cartilage Repair Research

Preclinical research in Australia examined AOD-9604 for cartilage repair applications, with published data from joint and in vitro cartilage models documenting potential chondroprotective effects separate from its lipolytic mechanism.

Signaling Summary

In research models, AOD-9604 has been studied for its lipid metabolism effects through mechanisms that may involve beta-3 adrenergic receptor signaling in adipose tissue, though the precise receptor mechanism remains an area of ongoing characterization in published literature. Researchers have also documented the absence of IGF-1 axis stimulation and GH receptor anabolic binding that would be expected from full-length GH, positioning AOD-9604 as a fragment with selectivity for fat metabolism research applications.

Frequently Asked Questions

Source Research-Grade AOD-9604

Spartan Peptides supplies research-grade AOD-9604 at least 98% HPLC-verified purity with Certificate of Analysis. Domestic US supply, same-day dispatch before 2 PM. For in vitro research use only.

For in vitro research use only. Not for human consumption.